Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus ESTA Q1 2026 Earnings WiderthanExpected Loss Reflects RD and Commercial Investments Oxford Square Capital Corp Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines BATRK Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline TAP Q1 2026 Earnings Stellar EPS Beat of 67 Surprises Analysts GABC Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Margin Pressure